نتایج جستجو برای: graft versus host disease

تعداد نتایج: 1951470  

Journal: :Haematologica 2016
Bipin N Savani Myriam Labopin Didier Blaise Dietger Niederwieser Fabio Ciceri Arnold Ganser Renate Arnold Boris Afanasyev Stephane Vigouroux Noel Milpied Michael Hallek Jan J Cornelissen Rainer Schwerdtfeger Emmanuelle Polge Frédéric Baron Jordi Esteve Norbert C Gorin Christoph Schmid Sebastian Giebel Mohamad Mohty Arnon Nagler

Increasing numbers of patients are receiving reduced intensity conditioning regimen allogeneic hematopoietic stem cell transplantation. We hypothesized that the use of bone marrow graft might decrease the risk of graft-versus-host disease compared to peripheral blood after reduced intensity conditioning regimens without compromising graft-versus-leukemia effects. Patients who underwent reduced ...

Journal: :Haematologica 2015
Joseph Pidala Jongphil Kim Melissa Alsina Ernesto Ayala Brian C Betts Hugo F Fernandez Teresa Field Heather Jim Mohamed A Kharfan-Dabaja Frederick L Locke Asmita Mishra Taiga Nishihori Leonel Ochoa-Bayona Lia Perez Marcie Riches Claudio Anasetti

Effective pharmacological strategies employed in allogeneic hematopoietic cell transplantation should prevent serious chronic graft-versus-host disease and facilitate donor-recipient immune tolerance. Based on demonstrated pro-tolerogenic activity, sirolimus (rapamycin) is an agent with promise to achieve these goals. In a long-term follow-up analysis of a randomized phase II trial comparing si...

Journal: :Journal of Medical Case Reports 2007
Sandra Silva José Maximino Rui Henrique Ana Paiva Jorge Baldaia Fernando Campilho Pedro Pimentel Alfredo Loureiro

Graft-versus-host disease is one of the most frequent complications occurring after haematopoietic stem cell transplantation. Recently, renal involvement has been described as a manifestation of chronic graft-versus-host disease. Immunosuppression seems to play a major role: clinical disease is triggered by its tapering and resolution is achieved with the resumption of the immunosuppressive the...

2018
William R. Drobyski Aniko Szabo Fenlu Zhu Carolyn Keever-Taylor Kyle M. Hebert Renee Dunn Sharon Yim Bryon Johnson Anita D’Souza Mary Eapen Timothy S. Fenske Parameswaran Hari Mehdi Hamadani Mary M. Horowitz J. Douglas Rizzo Wael Saber Nirav Shah Bronwen Shaw Marcelo Pasquini

We conducted a phase 2 study in which patients undergoing allogeneic hematopoietic stem cell transplantation received tocilizumab in addition to standard immune suppression with tacrolimus and methotrexate for graft-versus-host disease prophylaxis. Thirty-five patients were enrolled between January 2015 and June 2016. The median age of the cohort was 66 (range: 22-76). All patients received bus...

Journal: :Biology of Blood and Marrow Transplantation 2016

2017
Shoba Amarnath Arian Laurence Nathaniel Zhu Renato Cunha Michael A. Eckhaus Samuel Taylor Jason E. Foley Monalisa Ghosh Tania C. Felizardo Daniel H. Fowler

CD4+ T-helper subsets drive autoimmune chronic graft-versus-host disease, a major complication after allogeneic bone marrow transplantation. However, it remains unclear how specific T-helper subsets contribute to chronic graft-versus-host disease. T-helper type 1 cells are one of the major disease-mediating T-cell subsets and require interferon-γ signaling and Tbet expression for their function...

2009
Gerhard Behre Thomas Weber Sebastian Theurich Maximilian Christopeit

INTRODUCTION The existence of a graft-versus-lymphoma effect is well established. When lacking a firm diagnosis, however, the clinician is challenged to to weigh the potential benefits of the graft-versus-lymphoma effect against potential dangers of graft-versus-host disease as well as against generalized (viral) infections. CASE PRESENTATION We present evidence for a graft-versus-lymphoma ef...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید